BBC vs SBIO

Virtus Biotech Clinical Trials ETF against ALPS Medical Breakthroughs ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
30%
43 shared positions
Fee gap
15 bp
SBIO is cheaper
1-year return gap
17.7 pts
BBC is ahead
Larger fund
SBIO
$200M

Side by side

BBCSBIO
FundVirtus Biotech Clinical Trials ETFALPS Medical Breakthroughs ETF
IssuerVirtusALPS
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.65%0.50%
Assets$42M$200M
Average daily dollar volume$866K$2.6M
ListedDec 16, 2014Dec 30, 2014
FrenzyCap score4457
1-month return−11.6%−13.7%
3-month return−14.0%−15.8%
Year to date+14.5%+7.5%
1-year return+52.3%+34.6%
30-day volatility32.2%28.1%
Worst drawdown, 1 year−22.8%−23.8%
Trailing 12-month yield1.49%—
Holdings12589
Top 10 weight16.2%34.8%
Look-through P/E——
Holdings vs fair value+16.7%+12.5%
Holdings above 200-day average46%43%
Net flow, latest 3 reported months+$5.1M thru Jul 2026+$17M thru May 2026
30-day implied volatility43.3%37.3%
Holdings as ofas of Apr 30, 2026SEC filingas of May 31, 2026SEC filing

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

35% of BBC · 61% of SBIO
HoldingBBCSBIO
ORKA1.68%1.80%
SYRE1.64%3.68%
DNTH1.54%2.63%
CGON1.21%3.35%
RLAY1.19%1.60%
TYRA1.14%1.15%
EWTX0.97%2.33%
PVLA0.96%1.03%
XENE0.94%2.90%
AMLX0.90%1.01%
CLDX0.88%1.33%
BCAX0.86%0.88%
AVBP0.94%0.85%
CELC0.85%3.92%
MLTX0.82%0.88%
TSHA0.82%1.02%
RAPP0.81%1.20%
APGE0.80%2.93%
DNLI0.77%2.13%
MBX0.75%0.90%
STOK0.75%1.13%
SION0.67%1.23%
KYMR0.67%4.24%
CRVS1.34%0.66%
IDYA0.63%1.65%

Sector mix of the stock holdings

SectorBBCSBIOGap
Health Care92.6%100.0%−7.5%
Technology0.6%0.0%+0.6%

More: full overlap table · BBC holdings · SBIO holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.